
TheraSkin® is a biologically active cryopreserved real human skin allograft. TheraSkin has both living cells and a fully developed extracellular matrix (ECM) in its epidermis and dermis layers. The TheraSkin fully developed ECM provides, upon application, an “at ready” supply of growth factors, cytokines and collagen to jump start wound healing in non-progressing chronic wounds. TheraSkin is an effective natural barrier to control infection and assist in promotion of granulation tissue and epithelialization.
TheraSkin® is marketed by Soluble Systems and is provided by the Skin and Wound Allograft Institute (SWAI), a wholly owned subsidiary of LifeNet Health, Inc.
TheraGauze® is a moist nonadherent polymer wound interface dressing. Its patented Skin Moisture Rebalancing Technology (SMRT) allows TheraGauze to regulate moisture differentially across the wound bed, and to aid in wound healing without maceration. TheraGauze® is manufactures, distributed and marketed by Soluble Systems.